Bekaii-Saab, T., Okusaka, T., Goldstein, D., Oh, D., Ueno, M., Ioka, T., Fang, W., Anderson, E. C., Noel, M. S., Reni, M., Choi, H. J., Goldberg, J. S., Oh, S. C., Li, C., Tabernero, J., Li, J., Foos, E., Oh, C., & Van Cutsem, E. (2023). napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial. EClinicalMedicine, 58, . http://access.bl.uk/ark:/81055/vdc_100184748601.0x000002